| Literature DB >> 26548909 |
Juan Ji1,2, Yufeng Qin1,2, Jing Ren1,2, Chuncheng Lu1,2, Rong Wang3, Xiuliang Dai3, Ran Zhou1,2, Zhenyao Huang1,2, Miaofei Xu1,2, Minjian Chen1,2, Wei Wu1,2, Ling Song1,2, Hongbing Shen1,4, Zhibin Hu1,4, Dengshun Miao1,3, Yankai Xia1,2, Xinru Wang1,2.
Abstract
Mitochondria-related microRNAs (miRNAs) have recently emerged as key regulators of cell metabolism and can modulate mitochondrial fusion and division. In order to investigate the roles of mitochondria-related miRNAs played in obesity, we conducted comprehensive molecular analysis in vitro and in vivo. Based on high-fat-diet (HFD) induced obese mice, we found that hepatic mitochondrial function was markedly altered. Subsequently, we evaluated the expression levels of selected mitochondria-related miRNAs and found that miR-141-3p was up-regulated strikingly in HFD mice. To further verify the role of miR-141-3p in obesity, we carried out gain-and-loss-of-function study in human HepG2 cells. We found that miR-141-3p could modulate ATP production and induce oxidative stress. Through luciferase report gene assay, we identified that phosphatase and tensin homolog (PTEN) was a target of miR-141-3p. Inhibiting PTEN could alter the mitochondrial function, too. Our study suggested that mitochondria-related miR-141-3p induced mitochondrial dysfunction by inhibiting PTEN.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26548909 PMCID: PMC4637860 DOI: 10.1038/srep16262
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The liver and WAT were obviously abnormal in the 16-week-old HFD mice.
(A) The organ coefficient of liver and WAT were significantly increased in HFD mice. (B,C) HE staining of liver and WAT were shown. Scale bar, 50 μm. (B) Diffuse and marked fat accumulation in the liver of HFD mice compared with that of SD mice. (C) Increased volume of lipocytes in an abdominal fat pad from an HFD mouse compared with that from SD. The level of liver TC (D), TG (E) and ALT (F) were markedly higher in the HFD mice. *P < 0.05,**P < 0.01,***P < 0.001.
Figure 2The HFD mice were more vulnerable to oxidative damage and the antioxidant capacity was decreased.
(A) The DCF average fluorescent intensity was presented in histogram, the ROS production was significantly increased in HFD mice. (B) The MDA production was significantly increased in HFD mice. Antioxidant capacity, including T-AOC activities (C) and SOD activities (D) were measured. Both of them were significantly decreased in HFD mice. ATP production (E) was significantly increased in the HFD mice. Mitochondrial content (F) were similar between HFD mice and SD mice. The level of mitochondria-related miR-141-3p (G) was strikingly increased, and the levels of miR-196a-5p, miR-210-3p and miR-378a-3p were significantly decreased in the liver of 16-week-old HFD mice compared with 16-week-old SD mice. The level of mitochondria-related miR-141-3p (H) was markedly increased in the 16-weel-old HFD mice compared with the 8-week-old mice. Each data point represented the mean ± SE from three separate experiments in which treatments were performed in triplicate. *P < 0.05.
Figure 3The miR-141-3p may promote mitochondrial respiratory function of HepG2 cells.
(A,B) The oxygen consumption rates of basal respiration, ATP production, proton leak, maximal respiration, spare respiratory capacity and non-mitochondrial respiration of HepG2 cells transfected with miR-141-3p mimics or inhibitor were measured and calculated as averages for each phase. The ATP production was significantly increased in the HepG2 cells transfected with miR-141-3p mimics, while it was markedly decreased in the HepG2 cells transfected with miR-141-3p inhibitor. (C,D) The expression level of mtDNA-encoded subunits of the OXPHOS complexes was measured. (C) The expression level of mRNA (COX2, COX3, ND1) involving in OXPHOS was increased markedly in HepG2 cells transfected with miR-141-3p mimics. (D) The expression level of mRNA (COX2, COX3) was significantly decreased in HepG2 cells transfected with miR-141-3p inhibitor. *P < 0.05.
Figure 4The miR-141-3p may induce oxidative stress in the HepG2 cells.
The ROS production (A) and MDA content (C)were both significantly increased in HepG2 cells transfected with miR-141-3p mimics and both markedly decreased in HepG2 cells transfected with miR-141-3p inhibitor (B,D). Antioxidant capacity, including T-AOC activities and SOD activities were measured. Both of them were significantly decreased in HepG2 cells transfected with miR-141-3p mimics (E,G), and increased in HepG2 cells transfected with miR-141-3p inhibitor (F,H). Each data point represented the mean ± SE from three separate experiments in which treatments were performed in triplicate. *P < 0.05.
Figure 5PTEN was the target of the mitochondria-related miR-141-3p.
The expression level of PTEN mRNA in p53 pathway was significantly decreased in the HepG2 cells transfected with miR-141-3p mimics (A) while it was significantly increased in the HepG2 cells transfected with miR-141-3p inhibitor (B) and in the HFD mice livers (C). The representative of western blot of PTEN was shown. The protein level of PTEN was decreased in the HepG2 cells transfected withmiR-141-3p mimics (D) while it was increased in the HepG2 cells transfected with miR-141-3p inhibitor (E). (F) Sequence alignment of mitochondria-related miR-141-3p with 3′UTR of PTEN. Bottom: mutations in the 3′UTR of PTEN. (G) The firefly luciferase activity was normalized with Renilla. Each data point represented the mean ± SE from three separate experiments in which treatments were performed in triplicate. *P < 0.05, **P < 0.01, ***P < 0.001.
Figure 6The PTEN may involve in the mitochondrial activity of the HepG2 cells.
(A) The OCR of ATP production was measured in HepG2 cells transfected with PTEN siRNA and it was markedly increased. The ROS production (B) and MDA content (C) were both increased in the HepG2 cells transfected with PTEN siRNA. While T-AOC (D) and SOD activity (E) were both significantly reduced in the HepG2 cells transfected with PTEN siRNA. Each data point represented the mean ± SE from three separate experiments in which treatments were performed in triplicate. *P < 0.05.